Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $707M bought by 129 insiders at 88 companies
- $1.3B sold by 81 insiders outside a trading plan
- $1B sold by 336 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past week · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$247M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.4M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$66.3M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$62M
-
GMEGameStop CorporationRyan CohenCEO$17.1M
-
BORRBorr Drilling LimitedTor Olav TroimDirector$12.6M
-
AVRAnteris Technologies Global Corp.L1 Capital Pty Ltd10% owner$9.7M
-
PAMPampa Energia S.A.Damian Miguel MindlinVicepresident$5.6M
-
GPUSHyperscale Data, Inc.Milton C Ault IIIChair · +1 joint filer$5.1M
Biggest sales
Past week · by insider, all their filings added up · planned sales marked
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
CBRSCerebras Systems Inc.Dhiraj MallickCOO$80.8M
-
CRWDCrowdStrike Holdings, Inc.Michael SentonasPresident$64.2M
-
AAPLApple Inc ComTimothy D CookChair$63.8M
-
MPWRMonolithic Power Systems, Inc.Michael HsingCEO$40.3M
-
ACTEnact Holdings, Inc.Genworth Holdings, Inc.10% owner$37.1M
-
WDAYWorkday, Inc.David A Duffield10% owner$37.1M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Richard H Moore CEOFBNCFirst BancorpSale$1.5M 23,343 shares at $62.85 22% of stakeTraded Sep 28–29 Filed Sep 30
-
Thomas W Handley DirectorFULH. B. Fuller CompanyBuy$99K 2,000 shares at $49.41 New stakeTraded Sep 28 Filed Sep 30
-
Daniel L Florness DirectorFULH. B. Fuller CompanyBuy$100K 2,030 shares at $49.34 +150% to stakeTraded Sep 28 Filed Sep 30
-
Trangsrud Teresa J Rasmussen DirectorFULH. B. Fuller CompanyBuy$100K 2,042 shares at $48.96 +102% to stakeTraded Sep 28 Filed Sep 30
-
Charles T Lauber DirectorFULH. B. Fuller CompanyBuy$100K 2,005 shares at $49.87 +148% to stakeTraded Sep 29 Filed Sep 30
-
Srilata Zaheer DirectorFULH. B. Fuller CompanyBuy$100K 2,040 shares at $49.08 +152% to stakeTraded Sep 28–29 Filed Sep 30
-
Yair Nechmad ChairNYAXNayax Ltd.Buy$2.1M 46,935 shares at $44.90 +0.6% to stakeTraded Sep 28–29 Filed Sep 30
-
Keith R Larson DirectorNWPXNWPX Infrastructure, Inc.Planned sale$102K 1,000 shares at $102.20 6.4% of stakeTraded Sep 28 Filed Sep 30
-
Michael Catelani CFOANIXAnixa Biosciences, Inc.Buy$16K 5,500 shares at $2.84 +12% to stakeTraded Sep 30 Filed Sep 30
-
Robert George Culp IV CEOCULPCulp, Inc.Buy$12K 2,960 shares at $3.89 +2.2% to stakeTraded Sep 28 Filed Sep 30
-
Kun Dai CEOUXINUxin LimitedBuy$11K 8,440 shares at $1.26 New stakeTraded Sep 29 Filed Sep 30
-
Japan Post Holdings Co., Ltd. 10% ownerAFLAflac IncorporatedPlanned sale$1.4M 12,000 shares at $113.63 <0.1% of stakeTraded Sep 28 Filed Sep 30
-
Joseph P. Davy CEOPARABanzai International, Inc.Buy— 115,965 shares +343% to stakeTraded Sep 28 Filed Sep 30
-
Robert John Andrew Ryan DirectorASPIASP Isotopes Inc.Buy$22K 8,000 shares at $2.70 +1.2% to stakeTraded Sep 28 Filed Sep 30
-
Jingjing Eason Zhang CFOMNSOMINISO Group Holding LimitedBuy$340K 150,600 shares at $2.26 +62% to stakeTraded Sep 29 Filed Sep 30
-
Philip Andrew Smith CEOSNEXStoneX Group Inc.Planned sale$3.7M 56,250 shares at $65.69 7.1% of stakeTraded Sep 28 Filed Sep 29
-
Han Kyung Park SVP & GM of FPD OpsPLABPhotronics, Inc.Sale$289K 9,500 shares at $30.37 13% of stakeTraded Sep 25 Filed Sep 29
-
Michael Feld EVP, Chief Revenue OfficerBDXBecton, Dickinson and CompanyPlanned sale$14K 76 shares at $183.70 0.4% of stakeTraded Sep 28 Filed Sep 29
-
Joseph Cumello EVP & General Mgr.CIENCiena CorporationPlanned sale$569K 1,586 shares at $358.52 3.9% of stakeTraded Sep 25 Filed Sep 29
-
David S Marriott DirectorMARMarriott International, Inc.Sale$1.2M 3,500 shares at $352.09 1.2% of stakeTraded Sep 25 Filed Sep 29
-
Dominic Piscitelli CFOORICOric Pharmaceuticals, Inc.Planned sale$181K 13,400 shares at $13.53 16% of stakeTraded Sep 28 Filed Sep 29
-
Jayshree Ullal CEOANETArista Networks, Inc.Planned sale$13.2M 62,622 shares at $211.40 0.4% of stakeTraded Sep 25 Filed Sep 29
-
Adam Eltoukhy See RemarksIOTSamsara Inc.Planned sale$285K 7,306 shares at $39.07 1.9% of stakeTraded Sep 25 Filed Sep 29
-
Howard S Jonas DirectorZDGEZedge, Inc.Buy— 2,218,430 shares New stakeTraded Sep 25 Filed Sep 29
-
Kathleen Ford COOKURAKura Oncology, Inc.Planned sale$39K 3,668 shares at $10.75 2.5% of stakeTraded Sep 29 Filed Sep 29
-
Mollie Leoni Chief Medical OfficerKURAKura Oncology, Inc.Planned sale$310K 28,802 shares at $10.75 17% of stakeTraded Sep 29 Filed Sep 29
-
Brian T. Powl Chief Commercial OfficerKURAKura Oncology, Inc.Planned sale$250K 23,430 shares at $10.69 15% of stakeTraded Sep 28–29 Filed Sep 29
-
Kurtis Joseph Binder CFOARLOArlo Technologies, Inc.Planned sale$168K 13,358 shares at $12.58 3.7% of stakeTraded Sep 29 Filed Sep 29
-
Julie M. Williams SVP/Cont. Improvement and Opt.SWXSouthwest Gas Holdings, Inc.Sale$205K 2,500 shares at $81.81 8.6% of stakeTraded Sep 28 Filed Sep 29
-
Jeffrey R. Leitzell COOEOGEOG Resources, Inc.Planned sale$1.3M 9,039 shares at $140.61 9.1% of stakeTraded Sep 25 Filed Sep 29
-
Jeff Cislini SVP & General CounselRVMDRevolution Medicines, Inc.Planned sale$159K 765 shares at $207.32 1.5% of stakeTraded Sep 25 Filed Sep 29
-
William P Scully 10% ownerPRTAProthena Corporation plcBuy$890K 103,500 shares at $8.60 +124% to stakeTraded Sep 28 Filed Sep 29
-
Ivan Brockman DirectorVRAVera Bradley, Inc.Buy$10K 2,500 shares at $4.00 New stakeTraded Sep 25 Filed Sep 29
-
Pale Fire Capital SE 10% owner · +4 joint filersCOURCoursera, Inc.Buy$11.4M 2,332,742 shares at $4.87 +8.8% to stakeTraded Sep 25–29 Filed Sep 29
-
Robert Thomas Dechant CEOIBEXIBEX LimitedPlanned sale$225K 5,000 shares at $45.02 1.9% of stakeTraded Sep 25 Filed Sep 29
-
Jane Swift DirectorSPHSuburban Propane Partners, L.P.Sale$8,443 512 shares at $16.49 1.4% of stakeTraded Sep 28–29 Filed Sep 29
-
Ajit Jain Vice ChairmanBRK.ABerkshire Hathaway Inc.Sale$20M 39,700 shares at $503.09 37% of stakeTraded Sep 28 Filed Sep 29
-
Michael Edell CEOSNESSenesTech, Inc.Buy$1,289 2,000 shares at $0.6400 +22% to stakeTraded Sep 28 Filed Sep 29
-
Anton Reingold See RemarksGDEVGDEV Inc.Sale$201K 18,209 shares at $11.03 4.7% of stakeTraded Sep 28 Filed Sep 29
-
3D Investment Partners Pte. Ltd. Insider · +1 joint filerMNOVMediciNova, Inc.Sale$1.7M 640,000 shares at $2.70 12% of stakeTraded Sep 25 Filed Sep 29
-
Kevin McCulloch See RemarksXERSXeris Biopharma Holdings, Inc.Planned sale$250K 25,000 shares at $10.00 1.5% of stakeTraded Sep 28 Filed Sep 29
-
Ryan Cohen CEOGMEGameStop CorporationBuy$10.6M 450,000 shares at $23.48 +1.1% to stakeTraded Sep 29 Filed Sep 29
-
Pradheepa Raman Chief People OfficerGFSGlobalFoundries Inc.Planned sale$105K 2,145 shares at $48.83 100% of stakeTraded Sep 28 Filed Sep 29
-
Life Insurance Co Nippon 10% ownerCRBGCorebridge Financial Inc.Buy$6.2M 178,840 shares at $34.52 +0.1% to stakeTraded Sep 25 Filed Sep 29
-
William B. Horne CEOGPUSHyperscale Data, Inc.Buy$17K 100,000 shares at $0.1700 +33% to stakeTraded Sep 29 Filed Sep 29
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.6M 9,500 shares at $480.85 2.8% of stakeTraded Sep 28 Filed Sep 29
-
Neto Bruno Guicardi Pres. of N. Am. and Europe OpsCINTCI&T IncBuy$1,755 581 shares at $3.02 +0.6% to stakeTraded Sep 24 Filed Sep 29
-
Yat Tung Lam COOCRDOCredo Technology Group Holding LtdPlanned sale$20.6M 100,000 shares at $206.29Traded Sep 25 Filed Sep 29
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.